Order Entry
Netherlands
ContactUsLinkComponent
Human recombinant IL-15 mutant (from CHO cells)
Human recombinant IL-15 mutant (from CHO cells)
Catalog # PRSI90-504
Leverancier:  ProSci Inc.
CAS-nummer:  
Human recombinant IL-15 mutant (from CHO cells)
Catalog # PRSI90-504
Leverancier:  ProSci Inc.
CAS-nummer:  

Specificaties

  • Pk:
    50 µG
  • Protein/peptide type:
    Recombinant
  • Source:
    CHO cells
  • Species:
    Human
  • Tag sequence:
    Fc Tag
  • Storage conditions:
    Stable for at least 1 year after receipt when stored at −20 °C. Working aliquots are stable for up to 3 months when stored at −20 °C.
  • Biological activity:
    This mutant IL-15/Fc fusion protein specifically binds to the IL-15R, competitively inhibits IL-15-triggered cell proliferation, promotes transplant tolerance, does not activate the STAT-signaling pathway, and exerts a prolonged circulating half-life caused by the modified Fc domain.
  • Protein synonyms:
    Interleukin-15
  • Protein/peptide name:
    IL-15 mutant
  • Purity:
    >98% (SDS-PAGE)
  • Sequence:
    49-162
  • Formulation:
    Lyophilized from 0.2um-filtered solution in PBS.

Specificaties

Over dit artikel

Interleukin-15 (IL-15) has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. IL-15 participates in the development of important immune antitumour mechanisms. It activates CD8(+) T cells, natural killer (NK) cells, NK T cells, and can promote the formation of antitumour antibodies. IL-15 can also protect T effector cells from the action of T regulatory cells and reverse tolerance to tumour-associated antigens. In pre-clinical studies IL-15 has been found to demonstrate potentiated antitumour effects following pre-association with IL-15Ralpha, or when used in combination with chemotherapy, adoptive therapy, monoclonal antibodies, and tumour vaccines.

Fusion-Tag: Fc Tag

This recombinant proteins is for research use only.